Funding for this research was provided by:
European Union’s Horizon 2020 research and innovation programme (754425)
First Online: 11 February 2020
Compliance with Ethical Standards
: This study was funded by ZonMW—The Netherlands Organization for Health Research and Development (Project Number 849100006). In addition, funding was received from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No 754425.
: Sieta T. de Vries, Petra Denig, Corine Ekhart, Peter G.M. Mol, and Eugene P. van Puijenbroek declare that they have no conflict of interest.
: No ethical approval was necessary for this study in which observational data from a questionnaire-based prospective cohort study was used.
: This study was part of a wider project assessing gender differences in adverse drug reactions. The data used in the project, including the data that support the findings of this study, are described in DataverseNL available at ExternalRef removed.